Troglitazone improves whole-body insulin resistance and skeletal muscle glucose use in type II diabetic patients.
Year: 2001
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: I Yokoyama, K Yonekura, T Moritan, M Tateno, T Momose, K Ohtomo, Y Inoue, R Nagai
Institution: The University of Tokyo
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2266666897